Tempus AI Inc (TEM) Q3 2026 Earnings Call Highlights: Revenue Jumps 23% to $411. ...
Tempus AI Inc (TEM) posts 32% oncology volume growth, lands $192.5 million in new pharma collaborations with BMS and Moderna/Merck, and lifts its 2026 revenue outlook to $1.60-$1.605 billion. Related Stocks: TEM ,